作者: J. Couzin
DOI: 10.1126/SCIENCE.315.5814.924
关键词: Device Approval 、 Internal medicine 、 MEDLINE 、 Oncology 、 Food and drug administration 、 Cancer 、 Medicine 、 Test (assessment) 、 Genetic testing 、 Neoplasm Recurrence 、 Predictive value of tests 、 Multidisciplinary
摘要: DIAGNOSTICSLast week, the U.S. Food and Drug Administration issued its first-ever approval of a multigene prognostic test 2 days later held contentious meeting to discuss more stringent oversight this area. ([Read more][1].) [1]: http://www.sciencemag.org/cgi/content/full/315/5814/924